Omega Therapeutics, Inc. (OMGA)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -62.77 Million USD | -17.97% |
| 2022 | -3.11 Million USD | -150.76% |
| 2021 | -1.24 Million USD | -8.46% |
| 2020 | -1.14 Million USD | -44.33% |
| 2019 | -794 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 544 Thousand USD | 168.69% |
| 2024 Q2 | 1.52 Million USD | -1424.63% |
| 2023 Q1 | -791 Thousand USD | -36.38% |
| 2023 FY | -3.67 Million USD | -17.97% |
| 2023 Q4 | -792 Thousand USD | 23.33% |
| 2023 Q3 | -1.03 Million USD | 2.55% |
| 2023 Q2 | -1.06 Million USD | -34.01% |
| 2022 Q2 | -842 Thousand USD | 12.11% |
| 2022 Q1 | -958 Thousand USD | -299.17% |
| 2022 FY | -3.11 Million USD | -150.76% |
| 2022 Q4 | -580 Thousand USD | 20.11% |
| 2022 Q3 | -726 Thousand USD | 13.78% |
| 2021 Q4 | -240 Thousand USD | 40.0% |
| 2021 Q2 | -300 Thousand USD | 0.66% |
| 2021 Q1 | -302 Thousand USD | 98.57% |
| 2021 FY | -1.24 Million USD | -8.46% |
| 2021 Q3 | -400 Thousand USD | -33.33% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | -1.14 Million USD | -44.33% |
| 2020 Q4 | -21.06 Million USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 FY | -794 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 265.089% |
| Alkermes plc | 1.37 Billion USD | 104.567% |
| Agenus Inc. | 139.61 Million USD | 144.963% |
| Aptorum Group Limited | -1.11 Million USD | -5531.621% |
| Ardelyx, Inc. | 106.66 Million USD | 158.855% |
| Dyadic International, Inc. | 922.95 Thousand USD | 6901.509% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 398.063% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -35803.639% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -369.948% |
| Novavax, Inc. | 639.93 Million USD | 109.81% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -34.023% |
| Pyxis Oncology, Inc. | -2 Million USD | -3038.75% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -12048.135% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 429.649% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -141963.456% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -11811.765% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 36.085% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 7927.307% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -76454.878% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 146.408% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 897.548% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 35.25% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 104.136% |
| AlloVir, Inc. | -398 Thousand USD | -15672.613% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 126.076% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 14905.425% |
| Bicycle Therapeutics plc | -129.52 Million USD | 51.533% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 52412.5% |
| ChromaDex Corporation | 50.78 Million USD | 223.622% |
| Chimerix, Inc. | 324 Thousand USD | 19475.0% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -101.411% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 19.102% |
| CRISPR Therapeutics AG | 240.95 Million USD | 126.052% |
| Precision BioSciences, Inc. | 40.47 Million USD | 255.107% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 36.05% |
| Fortress Biotech, Inc. | 57.85 Million USD | 208.508% |
| Fortress Biotech, Inc. | 57.85 Million USD | 208.508% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 478.687% |
| ImmuCell Corporation | 4.39 Million USD | 1527.91% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 40.847% |
| Immix Biopharma, Inc. | -5468.00 USD | -1147943.16% |
| Incyte Corporation | 3.44 Billion USD | 101.825% |
| Innoviva, Inc. | 261.06 Million USD | 124.046% |
| IO Biotech, Inc. | -756 Thousand USD | -8203.571% |
| Jaguar Health, Inc. | 7.72 Million USD | 912.727% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -9354.066% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 152.42% |
| ContextLogic Inc. | 59 Million USD | 206.398% |
| MiMedx Group, Inc. | 266.84 Million USD | 123.525% |
| MEI Pharma, Inc. | 49.32 Million USD | 227.263% |
| NextCure, Inc. | -3.68 Million USD | -1603.99% |
| Onconetix, Inc. | -1.12 Million USD | -5469.282% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -116.705% |
| Opthea Limited | 21.72 Thousand USD | 289119.337% |
| Psyence Biomedical Ltd. | -240.00 USD | -26156150.0% |
| Vaxcyte, Inc. | -75 Million USD | 16.3% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -109405.286% |
| Precigen, Inc. | 106 Thousand USD | 59321.698% |
| Pharming Group N.V. | 220.1 Million USD | 128.521% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 12289.32% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 6321.506% |
| PureTech Health plc | -1.6 Million USD | -3816.095% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 157.187% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 65.396% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -38.5% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -185.51% |
| Acelyrin, Inc. | -115 Thousand USD | -54486.957% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -624464.72% |
| Summit Therapeutics Inc. | -2.05 Million USD | -2962.195% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -10893.87% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2239.732% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1649.617% |
| Elevation Oncology, Inc. | -39 Thousand USD | -160861.538% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1208.358% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1492.446% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 315.507% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 12756.25% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -114036.364% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 160.303% |
| Seer, Inc. | 7.02 Million USD | 993.34% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1533.874% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 391.367% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -52878.707% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -43706.394% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 10407.882% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 152.107% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 120.013% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1255400.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 2538.811% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -123618.959% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 313.615% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -26958.19% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -12659.146% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -784.404% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -13128.461% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -603505.769% |
| Soligenix, Inc. | 97.31 Thousand USD | 64609.665% |
| Century Therapeutics, Inc. | -10.8 Million USD | -480.766% |
| Kura Oncology, Inc. | -849 Thousand USD | -7293.993% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 6.451% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -42604.082% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 163.384% |
| Autolus Therapeutics plc | -4.86 Million USD | -1189.809% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 251.682% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -37266.071% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 166.272% |
| GRI Bio, Inc. | 10.84 Million USD | 679.052% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 2571.47% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -622.632% |
| IGM Biosciences, Inc. | -211.66 Million USD | 70.342% |
| INmune Bio, Inc. | 155 Thousand USD | 40600.0% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 201.35% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4067.521% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9580.718% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -214339.434% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 15715.672% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -3045.04% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -19955.911% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 166.456% |
| Verastem, Inc. | -62 Thousand USD | -101150.0% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 2678.029% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -23951.724% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2173.835% |
| Histogen Inc. | 3.76 Million USD | 1765.561% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 10995.052% |
| Surrozen, Inc. | -27.23 Million USD | -130.536% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1064.873% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -5110.062% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -144.765% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 413.061% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -3170354.545% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1134.794% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -93411.195% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 140.555% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 43155.556% |
| Apollomics, Inc. | 127 Thousand USD | 49529.134% |
| Amarin Corporation plc | 165.54 Million USD | 137.921% |
| Mesoblast Limited | -9.81 Million USD | -539.582% |
| Turnstone Biologics Corp. | 16.5 Million USD | 480.316% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 43.184% |
| Synaptogenix, Inc. | -6347.00 USD | -988949.945% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -122988.235% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 138.902% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 103.572% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2200.293% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 44.031% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 118.568% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -550171.739% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -902.796% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5565.614% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 957.816% |
| Insmed Incorporated | 239.63 Million USD | 126.196% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 1854.472% |
| OmniAb, Inc. | 14.66 Million USD | 528.002% |
| Alector, Inc. | -95.05 Million USD | 33.958% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 149.972% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -44.433% |
| Zai Lab Limited | 170.9 Million USD | 136.731% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 176.67% |
| Aura Biosciences, Inc. | -1.29 Million USD | -4747.49% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 48388.462% |
| Immunic, Inc. | -111 Thousand USD | -56454.054% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 495.957% |
| Veracyte, Inc. | 248.14 Million USD | 125.297% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.102% |
| FibroGen, Inc. | 128.9 Million USD | 148.699% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -11130219.149% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -438.061% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.847% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 16237.532% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 117.666% |
| TG Therapeutics, Inc. | 219.1 Million USD | 128.65% |
| Galecto, Inc. | -830 Thousand USD | -7463.253% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -4432.491% |
| Fortrea Holdings Inc. | 424 Million USD | 114.805% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 27.147% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -10971.429% |
| XBiotech Inc. | -1.74 Million USD | -3499.484% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5565.614% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -35.084% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 16.892% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 185.521% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 473.594% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 116.136% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -26.443% |
| Vaxxinity, Inc. | -2.23 Million USD | -2709.982% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 119.212% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -454.361% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 356.738% |
| NexImmune, Inc. | -1.02 Million USD | -6024.558% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1162600.0% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -783.451% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.555% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -93836.583% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1667.812% |
| Ainos, Inc. | -253.73 Thousand USD | -24640.574% |
| Pluri Inc. | 322 Thousand USD | 19595.342% |
| Prothena Corporation plc | -129.2 Million USD | 51.413% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 224.494% |
| Celularity Inc. | 6.75 Million USD | 1029.312% |
| Rallybio Corporation | -150 Thousand USD | -41750.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -92.52% |
| MeiraGTx Holdings plc | 287 Thousand USD | 21972.822% |
| Omeros Corporation | -69.77 Million USD | 10.037% |
| Humacyte, Inc. | -76.55 Million USD | 17.995% |
| Immunocore Holdings plc | 248.39 Million USD | 125.273% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -313.837% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 200.63% |
| Blueprint Medicines Corporation | 236.58 Million USD | 126.534% |
| CalciMedica, Inc. | -58 Thousand USD | -108132.759% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -4302.174% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 316.056% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2107.278% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -103.386% |
| Pulmatrix, Inc. | -8.22 Million USD | -663.686% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -5265.385% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -15633.083% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 84.259% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2361.685% |
| Cytokinetics, Incorporated | -322.59 Million USD | 80.54% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 7381.596% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -18309.091% |
| Vor Biopharma Inc. | -3.49 Million USD | -1697.68% |
| Roivant Sciences Ltd. | 109.23 Million USD | 157.468% |
| Evogene Ltd. | 1.39 Million USD | 4587.134% |
| ProKidney Corp. | -3.16 Million USD | -1880.909% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -42.956% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1015.488% |
| CorMedix Inc. | -205.56 Thousand USD | -30438.232% |
| BioLineRx Ltd. | 1.1 Million USD | 5765.614% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 20.206% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -190127.273% |
| Atai Life Sciences N.V. | -5000.00 USD | -1255400.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -51414.455% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -65290.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -4419.438% |
| Sagimet Biosciences Inc. | 2 Million USD | 3238.75% |
| MediciNova, Inc. | 979.7 Thousand USD | 6507.541% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 25.551% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -66289.932% |
| GeoVax Labs, Inc. | -20.72 Million USD | -202.957% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 125.671% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1394.287% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 107.196% |
| Mereo BioPharma Group plc | 7.42 Million USD | 945.341% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -20150.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -523025.0% |
| Absci Corporation | -41.84 Million USD | -50.004% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1255400.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 17.805% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -2450.792% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 129.37% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -6571.095% |
| Allakos Inc. | -6.14 Million USD | -922.228% |
| Imunon, Inc. | -720 Thousand USD | -8618.689% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 9.016% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 113.191% |
| BioAtla, Inc. | -103.73 Million USD | 39.483% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -550171.739% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -35166.854% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 74.147% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -20084.887% |
| XOMA Corporation | 3.86 Million USD | 1725.874% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 10.43% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 524.327% |
| aTyr Pharma, Inc. | -2.38 Million USD | -2528.769% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 603.812% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -216365.517% |
| Viridian Therapeutics, Inc. | -1 Million USD | -6127.679% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 482884715.385% |
| Akari Therapeutics, Plc | -4000.00 USD | -1569275.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 109.856% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 32340.586% |
| UroGen Pharma Ltd. | 73.35 Million USD | 185.58% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -135.165% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 540797.674% |
| Orgenesis Inc. | -5.72 Million USD | -996.507% |
| Entera Bio Ltd. | -56 Thousand USD | -111998.214% |
| GH Research PLC | -315 Thousand USD | -19828.571% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -33114.286% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -11857.143% |
| Xencor, Inc. | -85.26 Million USD | 26.372% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -28307.934% |
| Replimune Group, Inc. | -2.65 Million USD | -2264.407% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -6169.751% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 135.298% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 32340.586% |
| Portage Biotech Inc. | -54 Thousand USD | -116150.0% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -66289.932% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -16551.194% |
| OncoCyte Corporation | 413 Thousand USD | 15299.758% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1396451.724% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -28276927.027% |
| Purple Biotech Ltd. | -196 Thousand USD | -31928.061% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 799.989% |
| scPharmaceuticals Inc. | 9.78 Million USD | 741.74% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -501.008% |
| HilleVax, Inc. | -2.15 Million USD | -2811.642% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -64616.495% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -418288.43% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -9297.455% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -272834.783% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -836213.108% |
| Savara Inc. | -44.26 Million USD | -41.826% |
| Curis, Inc. | 9.81 Million USD | 739.843% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2366.637% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -50205.318% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -3530.711% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -27432.895% |
| BeiGene, Ltd. | 2.07 Billion USD | 103.02% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2145.252% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 84.293% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 210.738% |
| Erasca, Inc. | -3.73 Million USD | -1582.074% |
| bluebird bio, Inc. | -4.03 Million USD | -1457.692% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -222364.384% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 103.296% |
| DBV Technologies S.A. | 15.72 Million USD | 499.129% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -222364.384% |
| Moderna, Inc. | 2.15 Billion USD | 102.913% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -6760.656% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 884.099% |
| Molecular Templates, Inc. | 50.39 Million USD | 224.566% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -11611.754% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 146.921% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -908.92% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -59.558% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 43.511% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1649.582% |
| MacroGenics, Inc. | 50.52 Million USD | 224.241% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -929.436% |
| Prime Medicine, Inc. | -147.9 Million USD | 57.557% |
| Aditxt, Inc. | -111.66 Thousand USD | -56119.774% |
| Adagene Inc. | 18.11 Million USD | 446.603% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 12963.73% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 144.775% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 139.772% |
| SciSparc Ltd. | 2.19 Million USD | 2958.607% |
| Vericel Corporation | 135.57 Million USD | 146.302% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -250508.807% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -202517.649% |
| Generation Bio Co. | -73.91 Million USD | 15.067% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -14264.989% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 214.933% |
| Invivyd, Inc. | -2.02 Million USD | -2995.414% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 79.133% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -60588.528% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 165.141% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 163.868% |
| ADMA Biologics, Inc. | 88.21 Million USD | 171.159% |
| Clene Inc. | 533 Thousand USD | 11877.674% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 360.378% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -6459.561% |
| GeoVax Labs, Inc. | -20.72 Million USD | -202.957% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 3257.696% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -32205.626% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 226.042% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -785.152% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -7408.971% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 175.256% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 85961.418% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 218.082% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 63.753% |
| Trevena, Inc. | 1.45 Million USD | 4414.433% |
| Surrozen, Inc. | -27.23 Million USD | -130.536% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -17683.286% |
| Cingulate Inc. | -582.91 Thousand USD | -10669.096% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -202400.0% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -218.671% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -829160.238% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -7025.426% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 109.222% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -6253.745% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -111317.77% |
| Kronos Bio, Inc. | 1.37 Million USD | 4675.437% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -16.974% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -21398.288% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -12755.458% |
| ImmunityBio, Inc. | -17.89 Million USD | -250.894% |
| Korro Bio, Inc. | -3.63 Million USD | -1629.339% |
| Kineta, Inc. | 5.43 Million USD | 1255.439% |
| BioVie Inc. | -229.37 Thousand USD | -27267.609% |
| Codexis, Inc. | 57.33 Million USD | 209.49% |
| Celularity Inc. | 6.75 Million USD | 1029.312% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1664.291% |
| Celcuity Inc. | -142.77 Thousand USD | -43868.705% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 124185.788% |
| Cibus, Inc. | 1.42 Million USD | 4514.557% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -16684.759% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -173.899% |
| IN8bio, Inc. | -2.5 Million USD | -2409.996% |
| Kodiak Sciences Inc. | -25.94 Million USD | -141.935% |
| Annexon, Inc. | -3.26 Million USD | -1821.488% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -2971.184% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -50.406% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 9908.594% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 108.063% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 136.296% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -3203.947% |
| Arcellx, Inc. | 108.27 Million USD | 157.975% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -93.936% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 179.257% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -196.78% |
| Moolec Science SA | -143.3 Thousand USD | -43705.171% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -48.341% |
| Geron Corporation | -123.5 Million USD | 49.171% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2009.796% |
| Royalty Pharma plc | 1.79 Billion USD | 103.499% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 10.437% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1737856.811% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 27229.404% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 43.656% |
| Humacyte, Inc. | -76.55 Million USD | 17.995% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -6513.645% |
| 89bio, Inc. | -273 Thousand USD | -22894.505% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -4894.033% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -7302.712% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -50936.585% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 5709.92% |
| Notable Labs, Ltd. | 113 Thousand USD | 55653.097% |
| Liquidia Corporation | 14.6 Million USD | 529.966% |
| Mustang Bio, Inc. | -2.22 Million USD | -2721.348% |
| Immunovant, Inc. | -231 Thousand USD | -27075.325% |
| Quantum-Si incorporated | 488 Thousand USD | 12963.73% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -12.988% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -209150.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 3471.375% |
| Acasti Pharma Inc. | -11 Thousand USD | -570581.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -30579.269% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9580.718% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 62.525% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 5632.884% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -16376.378% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3106.078% |
| PepGen Inc. | -1.18 Million USD | -5201.943% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -49329.134% |
| United Therapeutics Corporation | 2.07 Billion USD | 103.033% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -174.163% |
| Solid Biosciences Inc. | -76.56 Million USD | 18.009% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -75914.434% |
| Immuneering Corporation | -764.13 Thousand USD | -8115.139% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 94834.698% |
| Belite Bio, Inc | -399 Thousand USD | -15633.083% |
| XOMA Corporation | 3.86 Million USD | 1725.874% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -213.311% |
| Bionomics Limited | -434.44 Thousand USD | -14349.337% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5744.972% |
| uniQure N.V. | 2.21 Million USD | 2934.086% |
| Cassava Sciences, Inc. | -89.42 Million USD | 29.8% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 31.817% |
| Forte Biosciences, Inc. | -9000.00 USD | -697400.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -7417.964% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -14264.989% |
| Altimmune, Inc. | -65.37 Million USD | 3.974% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 117.34% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5744.972% |
| Compugen Ltd. | 31.45 Million USD | 299.571% |
| Peak Bio, Inc. | 367.76 Thousand USD | 17169.139% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 356.057% |
| Benitec Biopharma Inc. | 108 Thousand USD | 58225.0% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -80380.769% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -5118.204% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -3345.39% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -52652.101% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -5118.204% |
| Instil Bio, Inc. | -4.75 Million USD | -1219.912% |
| argenx SE | 1.1 Billion USD | 105.663% |
| Immunome, Inc. | -8.9 Million USD | -604.783% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -3221.429% |
| Verona Pharma plc | -679.62 Thousand USD | -9136.725% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -35771.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | -2532.075% |
| CervoMed Inc. | -1.29 Million USD | -4752.635% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -2508.018% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1214.109% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 2640.469% |
| Moolec Science SA | -143.3 Thousand USD | -43705.171% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -15284.898% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2249.779% |
| AnaptysBio, Inc. | 14.78 Million USD | 524.701% |
| Design Therapeutics, Inc. | -537 Thousand USD | -11589.944% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -14601.405% |
| NeurAxis, Inc. | 2.15 Million USD | 3010.691% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3025.21% |
| Lumos Pharma, Inc. | 2 Million USD | 3227.803% |
| Achilles Therapeutics plc | -4.73 Million USD | -1226.812% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -35771.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -59303.833% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 298.286% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 7381.596% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -5982.849% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -37.822% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 146088.372% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -7536.861% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -476986.183% |
| Palisade Bio, Inc. | 246 Thousand USD | 25618.293% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -190127.273% |
| Beam Therapeutics Inc. | -59.67 Million USD | -5.2% |
| Neurogene Inc. | -3.26 Million USD | -1824.433% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 145.053% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1600.298% |
| Sesen Bio, Inc. | 40 Million USD | 256.938% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -21036.364% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1458.838% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -556.23% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 545.845% |
| Athira Pharma, Inc. | -969 Thousand USD | -6378.328% |
| Vaccinex, Inc. | -16 Million USD | -292.246% |
| HCW Biologics Inc. | -574.82 Thousand USD | -10820.734% |
| XOMA Corporation | 3.86 Million USD | 1725.874% |
| Nektar Therapeutics | 53.47 Million USD | 217.385% |
| Arvinas, Inc. | 71.8 Million USD | 187.43% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 24.785% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -19395.342% |
| Rezolute, Inc. | -36 Thousand USD | -174275.0% |
| Clene Inc. | 533 Thousand USD | 11877.674% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -4888918.692% |
| BeyondSpring Inc. | 1.75 Million USD | 3685.094% |
| Synlogic, Inc. | -1.92 Million USD | -3162.734% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -169562.162% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -891.393% |
| Peak Bio, Inc. | 367.76 Thousand USD | 17169.139% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -231.039% |
| Krystal Biotech, Inc. | 47.6 Million USD | 231.866% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 144.493% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1349.254% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2324.476% |
| MannKind Corporation | 136.19 Million USD | 146.093% |
| Ikena Oncology, Inc. | -50.49 Million USD | -24.327% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 157.69% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1331.585% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -24810.714% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1255400.0% |
| Legend Biotech Corporation | 140.92 Million USD | 144.544% |
| Mural Oncology plc | -2.56 Million USD | -2345.462% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -11292.922% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -62675.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 402.472% |
| REGENXBIO Inc. | 53.02 Million USD | 218.379% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1071.842% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -32531.579% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -3524.423% |
| Vaxart, Inc. | -60.76 Million USD | -3.311% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -23788.804% |
| Cellectis S.A. | 18 Thousand USD | 348850.0% |
| Longeveron Inc. | 221 Thousand USD | 28504.977% |
| Repare Therapeutics Inc. | -80.07 Million USD | 21.6% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 105.743% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -4751.236% |
| Revolution Medicines, Inc. | -399.66 Million USD | 84.293% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -179257.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 128212.245% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.729% |
| Denali Therapeutics Inc. | -93.34 Million USD | 32.749% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -250508.807% |
| Veru Inc. | 7.56 Million USD | 929.707% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -41472.848% |
| Cingulate Inc. | -582.91 Thousand USD | -10669.096% |
| Passage Bio, Inc. | -3.72 Million USD | -1587.046% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -521113.882% |
| Exicure, Inc. | -1.42 Million USD | -4311.455% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -16290.339% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2422.42% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -12144.599% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 192.145% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -41859.935% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -6.028% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 16154.987% |
| OmniAb, Inc. | 14.66 Million USD | 528.002% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 413.985% |
| Lipocine Inc. | -2.85 Million USD | -2102.0% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -3306.131% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1000.351% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4067.521% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 183.349% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -96476.923% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 174.47% |
| Ocugen, Inc. | -33.53 Million USD | -87.181% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1885.294% |
| Q32 Bio Inc. | 578 Thousand USD | 10960.727% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -23588.679% |
| Alumis Inc. Common Stock | -1.28 Million USD | -4789.019% |
| Equillium, Inc. | 35.95 Million USD | 274.579% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -3577.504% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 12637.973% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1518405.08% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -24137.452% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 14950.537% |
| Dominari Holdings Inc. | 2.03 Million USD | 3178.715% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -34115.217% |
| vTv Therapeutics Inc. | -13.59 Million USD | -361.751% |
| Bio-Techne Corporation | 773.07 Million USD | 108.12% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 462.463% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 113.623% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -5269.974% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -161.781% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 636.676% |
| Nkarta, Inc. | -5.86 Million USD | -969.603% |
| BioCardia, Inc. | -7.24 Million USD | -765.982% |
| Iterum Therapeutics plc | -1.75 Million USD | -3487.143% |